Category: Vaccine

9 May 2024

Image source, Getty Images

Five babies have died from whooping cough as cases continue to rise in England, health officials have announced.

The UK Health Security Agency (UKHSA) reported 1,319 cases in England in March, after just over 900 in February, making the 2024 total nearly 2,800.

It fears this year could see lots of the bacterial infection. The last peak year, 2016, had 5,949 cases in England.

The infection can be particularly serious for babies and infants.

Half of cases seen so far this year have been in the under-15s, with the highest rates in babies under three months of age.

The five babies who died this year were all under three months old. These are the first deaths since 2019.

Other parts of the UK and Europe are also seeing a rising number of cases.

Known as pertussis or "100-day cough", the infection is a cyclical disease with peaks seen every three to five years.

UKHSA has said a steady decline in uptake of the vaccine and the very low numbers seen during the pandemic, as happened with other infections because of restrictions and public behaviour, were both factors in the rise in cases.

The agency said a peak year was therefore overdue.

In September 2023, the number of two-year-olds who completed their routine six-in-one vaccinations, which includes protection against pertussis, was 92.9%, compared with 96.3% in March 2014.

Uptake of the maternal pertussis vaccine, offered to women in every pregnancy, also dropped - from more than 70% in September 2017 to about 58% in September 2023.

Getting vaccinated while pregnant provides some protection to babies in the first months of life.

The first signs are similar to a cold, with a runny nose and sore throat.

After about a week, the infection can develop into coughing bouts that last a few minutes and are typically worse at night.

Young babies may make a distinctive "whoop" or have difficulty breathing after a bout of coughing.

The bacterial infections spreads through coughs and sneezes.

People of all ages can catch whooping cough, but it is most serious for young children and babies.

Health experts are urging those not vaccinated to come forward to get the jab.

Children who have not been vaccinated can still get the jab up to the age of 10.

Vaccination does not provide lifelong immunity against the disease, but subsequent infections tend to be mild.

Dr Gayatri Amirthalingam, from UKHSA, said: "Vaccination remains the best defence against whooping cough and it is vital that pregnant women and young infants receive their vaccines at the right time.

"Whooping cough can affect people of all ages, but for very young babies it can be extremely serious.

"Our thoughts and condolences are with those families who have so tragically lost their baby."

Prof Kamila Hawthorne, who chairs the Royal College of GPs, said: "It's highly concerning that such a high number of whooping cough cases have been confirmed.

"While whooping cough will be an unpleasant and uncomfortable experience for most patients, causing restless nights and leaving those affected with a shortness of breath, for some, it can be far more serious."

Follow this link:

Whooping cough: Cases up again as five infant deaths reported - BBC.com

ASTRAZENECA has wound down its Covid vaccine and will no longer make or distribute it because the pandemic is over.

The firm said demand is low as there are so many other jabs available.

It is another sign that the outbreak is consigned to history after the World Health Organisation last year declared the global emergency over.

The Oxford-AstraZeneca jab was the second to enter public rollouts after the UK was first to begin using Pfizers in December 2020.

The NHS mostly stopped using the vaccine after it was deemed risky for young people and Pfizer was better suited as a booster for the elderly.

Professor Adam Finn, of the Joint Committee on Vaccination and Immunisation, said: Were in a very different place with almost everyone in the population immune to the coronavirus so the need for this vaccine is evaporating.

The vaccine was linked to a rare but deadly form of blood clotting that has led some families to sue the company over the deaths and injuries of loved ones.

At least 81 people in the UK are confirmed to have died from the condition, according to reports.

Vaccine-induced thrombocytopenia and thrombosis (VITT) was only seen shortly after the jabs so people who received them years ago are safe now.

Newer jabs are more targeted to the current variants of Covid.

Dr Rachel Ward, a GP from Oxfordshire, said: "The AstraZeneca vaccine is not dangerous.

"In fact, it saved many lives during Covid.

"Like all vaccines and medications, it had some rare side effects which we understood well as it was given to so many people across the world, allowing us to collect lots of information quickly.

"You do not need to do anything if you have had an AstraZeneca Covid vaccine.

"If you need further vaccines going forward, you will be given another brand - but it does not matter if you had AstraZeneca previously.

"This move is a positive development with Covid protection, as we now have newer vaccines to replace it."

An AstraZeneca spokesperson said: We are incredibly proud of the role Vaxzevria played in ending the global pandemic.

According to independent estimates, over 6.5million lives were saved in the first year of use alone and over three billion doses were supplied globally.

Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic.

As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines.

This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorisations for Vaxzevria within Europe.

We will now work with regulators and our partners to align on a clear path forward to conclude this chapter and significant contribution to the Covid-19 pandemic.

The NHS is continuing its seasonal Covid booster rollout for elderly people and those with weak immune systems, using Pfizer and Moderna vaccines.

BRITISH scientists reckon they can make a vaccine for coronaviruses we do not even know about yet.

Cambridge University experts are developing a pandemic-proofing jab that triggers immunity to the basic building blocks that are common across a number of coronaviruses.

It could work against different viruses andvariantsby targeting shared parts that do not change when they mutate.

Typical vaccines target super-specific parts of the viruses and becomeless effectivewhen the bugs evolve.

Lab tests on mice suggest a single vaccine using the new technology can already defend against Sars, Covid and a number of high-risk coronaviruses known tospread between bats.

Researcher Rory Hills said: Our focus is to create a vaccine that will protect us against the nextcoronaviruspandemic and have it ready before the pandemic has even started.

Read the original:

AstraZeneca removes Covid vaccine after court papers reveal very rare side effect linked to deaths... - The Sun

(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.

Most Read from Bloomberg

Novavax will receive $500 million in upfront payments as well as a further $700 million if all development, regulatory and launch milestones are met, according to a statement Friday. Novavax, which will receive tiered royalties on any vaccine sales, said Sanofi is also taking a minority equity stake of about 5% in the US company.

Novavax shares rose as much as 146% in early trading in New York and the stock is on track for its biggest one-day increase on record. The stock was trading at $10.30 a share on Friday, although this is still well off a peak of about $320 in early 2021.

The pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly during the pandemic. Amid various setbacks, Sanofi and Novavax ceded tens of billions of dollars in sales to nimbler messenger-RNA developers including the Pfizer-BioNTech alliance and Moderna Inc.

Now, Sanofi will have the rights to drive sales of Novavaxs Covid-19 shot worldwide from next year, except for in India, Japan and South Korea, where Novavax already has advance purchasing agreements. The French drugmaker also has the sole license to use Novavaxs protein-based Covid shot in combination with its flu shot, which it said will offer patients enhanced convenience and protection against two serious respiratory viruses.

Sanofi will also have a non-exclusive license to use Novavaxs Matrix-M adjuvant in other vaccine products. Novavax will still have the right to develop its own combined Covid-flu vaccine at its own cost.

Story continues

Shares of Sanofi rose slightly in early trading in Paris. The stock was down about 5% in the past 12 months through Thursdays close.

The deal is a boost for Novavax which is in the midst of restructuring its business after a difficult 2023 when it had to issue a going concern warning about its ability to continue operating. Novavax reported a first-quarter net loss of $148 million, compared with a $294 million loss a year earlier.

Read More: Novavax Falls After Warning of Substantial Doubt Over Future

At first glance the deal seems surprising for Sanofi but its likely a strategic move, said Mila Bankovskaia, a Bloomberg Intelligence analyst.

Moderna and Pfizer are both assessing mRNA-based combination vaccines, and though Sanofi believes its non mRNA-based flu product wont be improved, the potential to offer a non-mRNA-based combination as an alternative looks a sensible move, she said.

(Updates with shares.)

Most Read from Bloomberg Businessweek

2024 Bloomberg L.P.

More:

Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal - Yahoo Canada Finance

THE HEARTBROKEN parents of a baby girl who died of whooping cough shared her heartbreaking final moments.

Little Evie-Grace was just 15 days old when she passed away from the contagious bacterial infection on May 3.

Her parents described the symptoms she experienced in her final days as she rapidly deteriorated in health, following reports that five babies have died of whooping cough this year.

Evie-Grace's dad, Reece Lewis, said his daughter had been "perfectly fine" in the first few days of her life.

"It was around day seven when we really started to worry," he told ITV News.

"In the last two to three days, of her life, it was when it really went bad and she just deteriorated so quickly - it was unreal."

Whooping cough - also known as pertussis - is a bacterial infection of the lungs and breathing tubes that can be especially dangerous to young babies.

Starting off with cold like symptoms and progressing into nasty coughing bouts, the illness gets its name from the distinctive whoop sound some people make when they gasp for breath between coughs.

Reece recalled how distressing it had been to watch little Evie-Grace get sicker.

"The worrying sign is when they're coughing, going bright red and then going silent.

"That's what Evie was doing. Her first cough would be a normal cough and then she would go silent, and you can hear that hear that she's so blocked up she can't get the cough out.

"She's struggling to breathe and going bright red."

Mum Caitlin added that her daughter had brought up "secretions" every time she coughed.

It's common for someone with whooping cough to bring up a thick mucus, the NHS notes.

The UK Health Security Agency has warned that a drop in whooping cough vaccine uptake could be to blame to rising rates of the illness.

The free NHS jab is offered to pregnant women between 16 to 32 weeks, as well as to babies at eight, 12 and 16 weeks as part of the 6-in-1 vaccine.

As infants are particularly vulnerable to whooping cough in the weeks before they can get a jab, having the whooping cough vaccine as a mum can pass on immunity to your baby, reducing their risk of illness by 92 per cent.

Caitlin did have a whooping cough vaccine before little Evie-Grace was born.

But UKHSA warns that most infant deaths from whooping cough tend to occur in babies born to unvaccinated mums.

Eighty per cent of infant deaths since 2012 21 out of 26 were in babies whose mothers weren't vaccinated against whooping cough.

Of the mums of five babies that passed away between January and March this year, it's thought that three had received the preventative jab.

Evie-Grace's parents said they weren't aware of how dangerous whooping cough could be before their baby succumbed to the illness.

Reece said: "I didn't really know anything about this whooping cough to be honest.

"I know Caitlin had to have the vaccine during her pregnancy, but I didn't know what it is or what is was for."

Now, the parents want more people to understand the signs of whooping cough.

They are alsofundraisingfor the children's hospital which helped Evie-Grace in her final days.

Whooping cough has seen a huge surge in cases in the first three months of this year - 2,793, up from the 853 cases and one death recorded during the whole of 2023.

Experts have warned that the number of deaths might continue to rise over the next few months.

Writing for theDaily Mail, Dr Saleyha Ahsan said: "There is, inevitably, a lag between deaths and official reported figures, so already, by mid-May, the number of deaths is thought to be higher.

"And with paediatric intensive care units now on 'surge capacity' because of both pertussis, and measles - which means in essence there are many cases - that number may well, tragically, rise."

WHOOPING cough is a bacterial infection of the lungs and breathing tubes.

The first signs of the condition tend to be similar to a cold - such as a runny nose, a sore throat, red and watery eyes, and a slightly raised temperature.

After about a week, other signs start to appear. These include:

The cough may last several weeks or months.

Babies under six months have an increased risk of problems such as dehydration, breathing problems, pneumonia and seizures.

Older children and adults may experience sore ribs, hernia, middle ear infections, and urinary incontinence.

Source: NHS

Meanwhile, Paul Hunter - a professor in medicine at the University of East Anglia - warned that we might be on the cusp of the worst whooping cough outbreak in 40 years.

Waning whooping cough vaccination rates have been blamed for the spiralling case numbers in England.

Just 61 per cent of pregnant women in England were vaccinated in 2023, down from 71 per cent in 2020.

Meanwhile, the number of two-year-olds who completed their six-in-one vaccinations as of September 2023 was 92.9 per cent, compared with 96.3 per cent in March 2014.

But other factors are also contributing to the rise in infections in England and other countries, experts say.

The UKHSA said the bug peaks every three to five years and the last spike in the UK was in 2016, meaning a peak year in cases is "overdue".

Nationwide Covid-19 lockdowns also played their role.

Dr Mary Ramsay, a consultant epidemiologistat UKHSA told ITV News: "We're playing a kind of catch-up now, we're getting the cases we would have got during the pandemic.

"Plus, because there's been no circulation, it means there's less immunity across the adult population and older children and so it's spreading in that older age group.

"Unfortunately, those those individuals may be passing the infection on to people who are vulnerable."

The whooping cough vaccine is routinely given as part of the:

If you're pregnant you should also have the whooping cough vaccine ideally between 16 and 32 weeks.

Read the original:

Brave parents of 15-day-old baby girl who died of whooping cough share her heartbreaking final moments... - The Sun

Five babies have died of whooping cough amid fears of the worst outbreak in 40 years.

Almost 3,000 cases have been reported so far this year, three times the total for the whole of 2023.

The babies, who were all under three months, died from January to March.

Experts blame the surge in infections on a fall in vaccination uptake, a less effective jab and reduced community immunity caused by lockdowns. It is believed that three of the five grieving mothers had jabs during pregnancy to protect their children.

Doctors said last night that vaccination remained the best defence and urged parents to check their children's jabs were up to date. Data shows the number of deaths so far this year is the highest since 2014.

Dr Saleyha Ahsan warned that the overall number of whooping cough deaths 'may well rise', with reported figures expected to increase by mid-May.

She wrote in an article for the Daily Mail: 'There is, inevitably, a lag between deaths and official reported figures, so already, by mid-May, the number of deaths is thought to be higher.

'And with paediatric intensive care units now on 'surge capacity' because of both pertussis, and measles which means in essence there are many cases that number may well, tragically, rise.'

Click here to resize this module

The first signs of the illness, which is also known as pertussis or the '100-day cough', are similar to a cold. But after about a week it can develop into long coughing bouts that are typically worse at night.

As contagious as measles, whooping cough can be severe in babies under six months and lead to long-term complications.

It is the latest disease associated with the Victorian era to make a comeback, with similar outbreaks of measles and scarlet fever.

Prior to routine vaccination being introduced in 1957, outbreaks in the UK could affect up to 150,000 people and kill 300 in a single year.

Gayatri Amirthalingam, consultant epidemiologist at the UK Health Security Agency, yesterday sent her condolences to 'those families who have so tragically lost their baby'.

She added: 'Vaccination remains the best defence against whooping cough and it is vital that pregnant women and young infants receive their vaccines at the right time.

'Whooping cough can affect people of all ages but for very young babies it can be extremely serious.' Paul Hunter, professor in medicine at the University of East Anglia, said the latest rise in cases was fuelled by factors including falling vaccination uptake and reduced community transmission during lockdowns.

A newer vaccine introduced in the 1990s because it is safer with fewer side effects may also be slightly less effective, he suggested. 'If it is true that three of these women were vaccinated, it is quite worrying,' he said.

'It used to be much more common in the last century up until the vaccine was introduced. However, this current year looks like we may see more cases than we have seen in any of the last 40 years.'

Just one baby died last year from whooping cough, the first fatality since 2019. But officials are concerned that just a quarter of expectant mothers have had the pertussis jab offered between 16 and 32 weeks in parts of London. Rates are below half in other parts of the capital and in Birmingham. Uptake of the six-in-one jab offered to babies in the first four months of life are also at an all-time low. Just 91.8 per cent were fully vaccinated by their first birthday in 2022/23, according to NHS figures, below the 95 per cent target.

Of the 21 deaths from whooping cough between 2012 and 2023, 19 involved babies or mothers who were unvaccinated.

Yet of the recent fatalities, just two are not thought to have had the jab which was introduced in 2012 to protect newborns too young to be vaccinated themselves. Officials are now keen to ramp up vaccination rates to stifle the spread, which has been seen across all regions. Professor Sir Stephen Powis, medical director of the NHS, said: 'With cases of whooping cough continuing to rise sharply across the country, and these figures sadly showing five infant deaths, it is vital that families come forward to get the protection they need.

'If you are pregnant and have not been vaccinated yet, or your child is not up to date with whooping cough or other routine vaccinations, please contact your GP as soon as possible; and if you or your child show symptoms, ask for an urgent GP appointment or get help from NHS 111.'

GPs and the wider NHS have been alerted and are being encouraged to test anyone with symptoms to allow close monitoring of numbers.

Steve Brine, chairman of the Commons health committee, called for 'rapid action to prevent a further fall in the uptake of vaccinations across the country'.

Accusing ministers of failing to heed the lessons of Covid-19, he repeated calls to give medical and nursing students and recently retired staff a greater role in boosting declining rates.

He said: 'In the light of today's sad news, I urge the Government to rethink its approach and follow steps we have outlined to boost vaccination uptake across the country.'

A Department of Health spokesman said: 'We are committed to improving vaccination uptake rates to fully protect the public from preventable diseases and are urging people to make sure they and their children have received all appropriate jabs. The vaccine is proven to be safe and effective.'

See the rest here:

Doctor warns that number of whooping cough deaths 'may well rise' after outbreak of deadly disease kills five - Daily Mail

AstraZeneca (AZ), the makers of the Covishield vaccine have announced withdrawal of its Covid-19 vaccine due to its 'surplus of available updated vaccines' since the pandemic. "As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied. The pharmaceutical giant recently admitted that its Covid vaccine, sold under the brand name of Covishield in India, can cause a blood clot-related side effect, according to court papers being quoted in the UK media. (Also read: New Covid variant FLiRT spreads in US; do we need to worry? Symptoms to precaution, all you need to know)

According to media reports, the admission was made in a legal document submitted to the High Court in London in February for a group action being brought by 51 claimants. Ever since the disclosure people who took Covishield vaccine in the past have expressed worries regarding its side effects on health and also a rare condition Thrombosis with Thrombocytopenia Syndrome (TTS).

Should Covishield takers be worried about the vaccine's potential underlying effects on health? We asked a few experts.

"The decision to withdraw Covishield, which is the AstraZeneca vaccine manufactured by the Serum Institute of India, would depend on the reasons behind the withdrawal. If it's due to concerns about safety or efficacy, it's natural for people to have worries. However, it's essential to rely on guidance from health authorities and experts who evaluate the data comprehensively," says Dr Rahul Agarwal Consultant Internal Medicine CARE Hospitals Banjara Hills Hyderabad.

"If AstraZeneca or any other vaccine is withdrawn from circulation, it's typically because of concerns about safety or effectiveness that have been identified through ongoing monitoring and evaluation processes. In such cases, it's crucial for public health authorities to communicate transparently about the reasons for the withdrawal and provide guidance to healthcare providers and the public on next steps," says the expert.

"It's important to note that all vaccines, like any medical intervention, can have side effects, but these are typically outweighed by the benefits of vaccination, especially in the context of preventing severe illness and death from Covid-19. Health authorities usually conduct thorough assessments of vaccines to ensure their safety and efficacy, and any decision to withdraw a vaccine is made based on careful evaluation of available data," adds Agarwal.

"If you're concerned about the safety of a vaccine, it's best to consult with healthcare professionals who can provide personalized advice based on your individual health circumstances and the latest available information," he advises.

Dr Vishwesvaran Balasubramanian, Consultant Interventional Pulmonology and Sleep Medicine elaborates on the possible side effects of the vaccine, while assuring that it's very rare. However, one should be aware of the red flags.

"Vaccine induced thrombosis with thrombocytopenia syndrome (TTS) is an extreme immunological reaction that occurs after Covid-19 immunization. Initially thought to be associated with viral-vector-based vaccines like Johnson & Johnson/Janssen and AstraZeneca-Oxford, it was found that the side effect may also be seen with covishield vaccine. The immunological reaction leads to the activation of platelets and the coagulation system and can cause venous or arterial thrombosis and in certain circumstances can lead to secondary haemorrhage," says Dr Balasubramanian.

"Incidence of TTS among vaccine recipients appears to be higher even amongst younger individuals and recipients of a first dose and can manifest as clotting at unusual sites and sometimes with haemorrhage. Persistent and progressively worsening headache in addition to focal neurological symptoms like visual disturbances are described as early red flags for suspecting VITT in patients," adds Dr Balasubramanian.

Majority of these patients develop thrombosis in the lower extremities and lungs but can also develop clots at unusual sites including blood vessels supplying gut like splenic, portal or mesenteric, adrenal, cerebral, and even ophthalmic veins. Blood tests for evaluation may suggest reduced platelet count, elevated D-dimer and elevated anti-platelet factor-4 antibodies.

Constant patient monitoring and timely symptomatic interventions which may be medical or surgical are crucial for ensuring patient survivability.

However, Dr Balasubramanian says there is no need to panic as this side effect is a rare one and doesn't affect everyone who took the vaccine. He advises caution against any noticeable symptoms.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.

More:

Covishield rolled back; should those jabbed with it need to worry? Experts answer - Hindustan Times

Sanofi, a pharmaceutical company with Monroe County operations, is partnering with Novavax to help co-commercializeNovavax'sCOVID-19 vaccine.

Novavax announced the co-exclusive licensing agreement with Sanofi as it reported its 2024 first quarter results Friday.

The agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza combination vaccines, and developing multiple new vaccines utilizing Novavax's Matrix-MTM adjuvant, Novavax says.

The agreementrepresents a potential multi-billion dollar revenue opportunity for Novavax, according to the company, including:

$500 million upfront payment

Approximately $70 million equity investment in Novavax

Up to $700 million in COVID-19 and combination product near-term milestones, plus ongoing tiered royalties on product sales

Up to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvant

Sanofi will take a minority (<5%) equity investment in Novavax.

In late April, Sanofi reported a 2.4% gain in first-quarter revenue, as sales of vaccines and the anti-inflammatory drug Dupixent increased.

The rest is here:

Sanofi reaches agreement with Novavax regarding COVID-19 vaccine - 69News WFMZ-TV

SII ceased Covishield production due to decreased demand, focusing on Thrombosis transparency. Car cabin air contains carcinogens,... Read More SII ceased Covishield production due to decreased demand, focusing on Thrombosis transparency. Car cabin air contains carcinogens, impacting health. Vitamin D absorption hindered by various factors. Crucial Ayurvedic tips for summer heat and uterine conditions importance. Research in the American Journal of Hypertension revealed that adults consuming curd daily had lower blood pressure than non-consumers. Read Less Covishield side effects in packaging: Serum Institute of India In response to concerns over Covishield's side effects, the Serum Institute of India announced it ceased production and distribution of extra Covishield doses since December 2021 due to a notable decline in demand for prior vaccines. "We fully understand the ongoing concerns and it's crucial to emphasize our commitment to transparency and safety. From the outset, we have disclosed all rare to very rare side effects, including Thrombosis with Thrombocytopenia Syndrome, in the packaging insert in 2021," the SII spokesperson said. Car cabin air carries cancer causing chemicals: StudyA recent study raises concerns about our reliance on cars and their health implications. Published in Environmental Science & Technology, it reveals alarming levels of carcinogens in car cabin air, questioning the safety of our vehicular dependence. Common mistakes that affect Vitamin D absorption in the body Vitamin D is essential for bone health, immune function, and mood regulation. Despite supplement availability, low levels persist in many. Various factors can hinder its absorption, even with supplementation. Ayurvedic tips to beat summer heat Intense summer heat can lead to dehydration, heat exhaustion, and heatstroke. Prolonged exposure may cause sunburn, dehydration, and exacerbate existing health conditions like cardiovascular issues and respiratory problems. Read about few effective tips to help you beat summer heat. Uterine conditions women must be aware of Female reproductive health is integral to overall well-being. Uterine conditions significantly impact women's lives. Understanding these signs promptly aids in timely medical intervention. Knowledge of common uterine diseases is crucial for early detection and effective treatment. Eating curd daily can lower blood pressure? Read this Research in the American Journal of Hypertension revealed that adults consuming curd daily had lower blood pressure than non-consumers. This effect is linked to bioactive peptides in curd, known for their antihypertensive properties. Read about the potential health benefits offered by curd. Taking care of the heart during summer Summer's intense heat presents a distinct hurdle for cardiovascular health. Elevated temperatures correlate with a notable surge in cardiovascular disease (CVD) cases and fatalities. Research indicates a worrying trend: for every 1-degree Celsius temperature rise, CVD deaths increase by 2.1% and related illnesses by 0.5%. The TOI Lifestyle Desk is a dynamic team of dedicated journalists... Read More The TOI Lifestyle Desk is a dynamic team of dedicated journalists who, with unwavering passion and commitment, sift through the pulse of the nation to curate a vibrant tapestry of lifestyle news for The Times of India readers. At the TOI Lifestyle Desk, we go beyond the obvious, delving into the extraordinary. Consider us your lifestyle companion, providing a daily dose of inspiration and information. Whether you're seeking the latest fashion trends, travel escapades, culinary delights, or wellness tips, the TOI Lifestyle Desk is your one-stop destination for an enriching lifestyle experience.Read Less

end of article

See more here:

TOI Health News Morning Briefing | SII says vaccine side effects were disclosed in packaging, air inside - The Times of India

Let me tell you a medical story; you decide what you make of it. A person has a routine medical experience, the kind that all the persons neighbors have had as well. But afterward the person has weird symptoms, odd forms of pain, fatigue that just goes on and on and on.

The medical system cant help the person, so the person joins online communities that provide validation but not a cure. And the person develops a strong sense of betrayal, a belief that the system knew this was possible and just let it happen to them.

Now, let me give you a few more details. The person Im describing is an overweight 50-something Indiana man who watches Fox News and refused to wear a mask in the fall of 2020. The routine medical experience that preceded his mystery illness was his taking because his employer required it the Covid vaccine.

Are you suddenly forming a theory of whats wrong with him? Are you inclined toward psychosomatic explanations, thinking that hes taking the aches and pains of age and blaming them on the liberals and their vax?

Well, hold on, because Ive deceived you: Actually the person is a 35-year-old college-educated woman living in Brooklyn who works out five days a week, takes anti-anxiety medication and marched, fully masked, in the 2020 George Floyd protests. Her medical experience was getting Covid itself, despite her multiple vaccinations, and thereafter falling into a long-Covid trough she cant escape.

Now if you are, like her, a liberal professional, maybe youre less likely to default to psychosomatic explanations. On the other hand, if youre a conservative, her description may be what you expect to hear: Another blue-state long-Covid hypochondriac, obsessing over every twinge the way she obsesses over every passing mood, all to justify her desire to keep everybody in a mask.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit andlog intoyour Times account, orsubscribefor all of The Times.

Thank you for your patience while we verify access.

Already a subscriber?Log in.

Want all of The Times?Subscribe.

View original post here:

Opinion | What Medical Stories Do We Trust? - The New York Times

(Precision Vaccinations News)

TheAmerican Academy of Pediatrics journal recently confirmed data from the Vaccine Adverse Event Reporting System (VAERS) revealed over two dozen young children were incorrectly administered an adult RSV vaccine.

As reported in a Research Brief on May 9, 2024, these children were under the age of twobetween August 2023 and March 2024.

In January 2024, the Centers for Disease Control and Prevention (CDC) announced vaccine administration errors are known to occur.

Since the approval of RSV vaccines and the launch of a second-generationmonoclonal antibody,VAERS hasreceived reports of the Pfizer (Abrysvo) or GSK (Arexvy) vaccines being administered in error to children.

Additionally, the CDC and U.S. FDA have received reports of Arexvybeing administered in error to pregnant women.

According to the U.S.CDC,no special monitoring is needed when an adult RSV vaccine is administered to children. However, if eligible, children who receive an RSV vaccine in error should receive Beyfortusto prevent severe RSV disease.

Beyfortus(Nirsevimab)is a long-acting monoclonal antibody that prevents severe RSV disease. As of May 10, 2024, Beyfortus is reported to be about90%(95% CI = 75%96%) protective against RSV-associated hospitalization in infants in their first RSV season.

The CDC says that although both monoclonal antibodies and vaccines provide protection, howthey deliverprotection differs.

See more here:

Dozens of Infants Incorrectly Administered Adult RSV Vaccines - Precision Vaccinations